/ALT

Altimmune Inc

ALT

$3.27USD↓-0.61%-0.02 today

MARKET CAP

636.1M

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$3 – $3

52W RANGE

$3

$6

AI Summary

Stalk

TrimMedium

In the Stage 4 decline, ALT remains in a lower-high/lower-low sequence below all major EMAs. Price action is sideways and indecisive around the 9/21 EMA band with RSI neutral. Medium-term structure is bearish while the long-term trend stays up. Execution calls for trimming into rallies up to the EMA resistance zone.

↑$519M cash covers expenses through 2027 and 2029 pemvidutide readouts, reducing near-term financing risk.
↑Phase 2 pemvidutide trials for AUD and MASH show significant efficacy trends, opening multi-indication potential.
↓Zero revenues last quarter underscore reliance on equity raises and potential dilution.

Full analysis →

Buying

12

institutions

Selling

3

institutions

New Positions

5

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
BI Blackrock, Inc. Q2 2026	BUY	20.39 M	61.97 M	+7.59 M	+57.3%	0.00%
VG Viking Global Investors LP Q2 2026	BUYNEW	6.70 M	20.37 M	+6.70 M	+0.0%	0.06%
RC Ra Capital Management, L.P. Q2 2026	BUYNEW	6.50 M	19.76 M	+6.50 M	+0.0%	0.17%
WP Woodline Partners LP Q2 2026	BUYNEW	3.40 M	10.34 M	+3.40 M	+0.0%	0.03%
MM Millennium Management LLC Q2 2026	BUY	3.31 M	10.06 M	+50.93 K	+0.2%	0.00%
CA Citadel Advisors LLC Q2 2026	BUY	1.74 M	5.30 M	+760.19 K	+75.1%	0.00%
AC Aqr Capital Management LLC Q2 2026	BUY	1.22 M	3.71 M	+1.14 M	+1310.2%	0.00%
PA Point72 Asset Management, L.P. Q2 2026	SELL	486.88 K	1.48 M	+-178.41 K	-27.8%	0.00%
MG Man Group Plc Q2 2026	BUY	173.87 K	528.57 K	+44.03 K	+32.2%	0.00%
BH Brevan Howard Capital Management LP Q2 2026	BUY	130.78 K	397.57 K	+52.38 K	+64.6%	0.00%
JC Jpmorgan Chase & Co Q2 2026	SELL	106.62 K	313.48 K	+-20.87 K	-14.6%	0.00%
AC Adar1 Capital Management, LLC Q2 2026	BUYNEW	102.82 K	312.58 K	+102.82 K	+0.0%	0.01%
GM Grantham, Mayo, Van Otterloo & Co. LLC Q2 2026	SELL	83.84 K	254.86 K	+-42.55 K	-34.5%	0.00%
RT Renaissance Technologies LLC Q2 2026	BUYNEW	71.60 K	217.66 K	+71.60 K	+0.0%	0.00%
RC Rockefeller Capital Management L.P. Q2 2026	BUY	49.74 K	151.21 K	+3.37 K	+5.9%	0.00%